Diabetes mellitus impact on left ventricular assist device outcomes in heart failure patients: National Inpatient Sample study
Omar Obeidat, Abdullah H Abdullahi, Zeeshan Ismail, Mohamed F Ismail, Hamza Alzghoul, Mohammed Tarawneh, Rabab Elsadek, Hashim Al-Ani, Natalie P Hurlock, Andrew L Smock- Cardiology and Cardiovascular Medicine
- Molecular Medicine
Aim: Diabetes mellitus (DM) is a recognized risk factor for heart failure (HF), increasing the likelihood of requiring left ventricular assist device (LVAD) therapy. Objective: This retrospective cohort study aims to assess the impact of DM on LVAD patients, focusing on in-hospital mortality as the primary outcome. Methods: Utilizing the National Inpatient Sample administrative database, data from 11,506 adult HF patients who underwent LVAD implantation were analyzed. Results: Of the patients, 44.28% had diabetes. Adjusting for various factors, diabetic patients exhibited shorter hospital stays, lower admission costs and similar in-hospital mortality rates compared with non-diabetic patients. Conclusion: These findings enhance our understanding of the risks and benefits of LVAD therapy in patients with refractory HF and DM.